City Of Hope And Adagene Launch Phase 1 Clinical Trial To Explore Combination Therapy For Patients Battling Metastatic Colorectal Cancer
Benzinga Newsdesk 13 hours ago
News
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Study was designed by medical oncologist to accelerate lifesaving care to patientsCity of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, and Adagene Inc.
Study was designed by medical oncologist to accelerate lifesaving care to patients
City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, and Adagene Inc. ("Adagene") (NASDAQ:ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the launch of an innovative Phase 1 clinical trial to explore a new combination therapy for patients battling metastatic colorectal cancer, particularly for those whose disease has resisted standard treatments.
